Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 11:22:17 +0200Tue, 05 Mar 2024 15:23:00 +0100Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ameluzHuman medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ameluzTue, 05 Mar 2024 15:23:00 +0100Human medicineAmeluz : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500120046_en.pdfAmeluz : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500120046_en.pdfMon, 09 Jan 2012 01:00:00 +0100Human medicine